Yaz and Yasmin, manufactured by Bayer HealthCare Pharmaceuticals (Bayer), have been alleged to increase potassium levels and concomitant risks of blood clots, according to lawsuits filed by many plaintiffs. The United States Food and Drug Administration (FDA) approved Yasmin in 2001 for birth control and for treatment of premenstrual dysphoric disorder. Yaz was the best-selling birth control pill in the USA in 2008 and 2009. Yaz, Yasmin, and related pills were hot sellers for Bayer in 2010 with $1.6 billion in global sales, according to the Associated Press.
Generic versions of Yaz are Gianvi and Loryna. Yasmin generics are Ocella, Syeda, and Zarah. Other oral contraceptive brands are Beyaz and Safyral. Bayer has warned that women should not use Safyral if they have kidney, liver, or adrenal disease or if they have had blood clots, certain cancers, histories of heart attack or stroke, or if they may be pregnant.
Kentucky blood clot lawsuit attorneys are concerned about women throughout the USA suffering serious and potentially life-threatening blood clots in the deep veins of the legs, pelvis, or arms. Deep vein thrombosis (DVT) can block veins entirely or break off and migrate to a vital artery, threatening to restrict blood flow to vital organs. Kentucky blood clot lawsuit attorneys have offered to help injured parties seek financial compensation by DVT lawsuits for blood clot injuries through Yaz, Yasmin, Ocella, or other birth control they feel has negatively affected them, alleging manufacturer failures to study side effects of the drugs fully or to warn about their risks adequately.
DVTs usually occur in the deep veins of the legs or the pelvis. They can be extremely painful with swelling in the limbs affected. Kentucky blood clot lawsuit attorneys handling DVT lawsuits warn that dislodged DVTs may cause pulmonary embolisms, heart attack, or strokes. DVT symptoms, which may present as sudden, intense headaches, painful swellings in an arm or a leg, chest pain, or impaired vision, should receive immediate medical attention.
Preliminary results of a recent FDA Yasmin study show a 1.5-fold increased risk of blood clots for women who use Yaz and Yasmin compared to users of other hormonal contraceptives. An FDA advisory committee discussed the risks and benefits of birth control pills but reached no consensus on drug safety. In March 2012, however, The Washington Monthly and the British Medical Journal reported that the FDA advisory committee that decided to keep Yaz, Yasmin, and other birth control drugs on the market might have had a conflict of interests. It was stated in these reports that four of the FDA committee members in favor of the drugs had Bayer connections.
Kentucky blood clot lawsuit attorneys point out that in August 2009 the British Medical Journal published study findings that oral contraceptives increase the risk of pulmonary embolism from DVT 6.3 times. Compared to women using other oral birth control drugs, users of Yaz, Yasmin, and Ocella have nearly four times the risk of DVT.
In 2009 the FDA ordered Bayer to clarify alleged misstatements in Yaz/Yasmin advertising. According to Kentucky blood clot lawsuit attorneys engaged in DVT lawsuits, the FDA found that Bayer advertising overstated the drugs’ effect on acne and premenstrual dysphoric disorder while understating the risks. Such an alleged deception is a factor in the DVT lawsuits.
By March 2012, there were about 12,000 lawsuits pending in the USA alleging that Bayer failed to warn patients and physicians adequately of the increased risk of DVT side effects in the use of Yasmin and Yaz compared to the use of other oral contraceptives. Most are consolidated into a federal multi-district litigation case in the United States District Court for the Southern District of Illinois. Kentucky blood clot lawsuit attorneys believe that by separate consideration of DVT lawsuits the multidistrict litigation will achieve better results than would a class action lawsuit. Plaintiffs who do not reside in the Southern District of Illinois can still file a blood clot or DVT lawsuit with a local attorney. Just because a case is consolidated into one court, does not mean plaintiffs from across the nation can’t still file.
Kentucky Blood Clot Lawsuit Attorneys and DVT Lawsuit Attorneys
All users of Yaz, Yasmin, Gianvi, Loryna, Beyaz, Ocella, Safyral, Syeda, Zarah and the Ortho Evra contraceptive patch should do her research on the risks involved with her particular birth control, and be aware of the possible consequences. But for those that have dealt with serious injury and believe it could be caused the medication they have taken, it is important to contact Attorney Group for Kentucky to discuss your situation and find out if you might be eligible for compensation. Attorney Group for Kentucky wants to help answer your questions and connect you with affiliated Kentucky blood clot lawsuit attorneys or DVT lawsuit attorneys. Users may be entitled to compensation for damages incurred, depending on each individual situation. There is no upfront fee for asking questions from Attorney Group for Kentucky, so contact us today.